Daniel Weintraub
Impact in
- Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research
Papers in
- Neurology 231
- Parkinson's Disease Mechanisms and Treatments 226
- Neurological disorders and treatments 69
-
- Dementia and Cognitive Impairment Research 58
- Attention Deficit Hyperactivity Disorder 11
- Co-authors
- Andrew Siderowf (62 shared papers)Dag Aarsland (26 shared papers)John E. Duda (38 shared papers)Matthew B. Stern (29 shared papers)К. Ray Chaudhuri (24 shared papers)Sharon X. Xie (45 shared papers)David J. Burn (12 shared papers)Marc N. Potenza (9 shared papers)
- Journals
- Movement Disorders (74 papers)Parkinsonism & Related Disorders (29 papers)American Journal of Geriatric Psychiatry (20 papers)Neurology (20 papers)Journal of Parkinson s Disease (14 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Daniel Weintraub
358 papers receiving 27.8k citations
Daniel Weintraub's Hit Papers
Peers
Comparison fields: 5 of 172
- Neurology 17.7k
- Psychiatry and Mental health 4.5k
- Neurology 1.6k
- Cognitive Neuroscience 3.7k
- Cellular and Molecular Neuroscience 3.4k
Countries citing papers authored by Daniel Weintraub
This map shows the geographic impact of Daniel Weintraub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Weintraub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Weintraub more than expected).
Fields of papers citing papers by Daniel Weintraub
This network shows the impact of papers produced by Daniel Weintraub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Weintraub. The network helps show where Daniel Weintraub may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Weintraub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 369 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines Hit paper breakdown → | 2012 | 1997 |
| 2 | Impulse Control Disorders in Parkinson Disease Hit paper breakdown → | 2010 | 982 |
| 3 | Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Hit paper breakdown → | 2009 | 946 |
| 4 | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease Hit paper breakdown → | 2011 | 867 |
| 5 | Parkinson disease-associated cognitive impairment Hit paper breakdown → | 2021 | 856 |
| 6 | Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease Hit paper breakdown → | 2006 | 762 |
| 7 | Cognitive decline in Parkinson disease Hit paper breakdown → | 2017 | 734 |
| 8 | Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review Hit paper breakdown → | 2019 | 682 |
| 9 | MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD‐MCI Hit paper breakdown → | 2011 | 590 |
| 10 | Mild cognitive impairment in Parkinson disease Hit paper breakdown → | 2010 | 572 |
| 11 | Depression rating scales in Parkinson's disease: Critique and recommendations Hit paper breakdown → | 2007 | 528 |
| 12 | Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease Hit paper breakdown → | 2006 | 490 |
| 13 | 2009 | 396 | |
| 14 | 2010 | 381 | |
| 15 | Effect of Citalopram on Agitation in Alzheimer Disease Hit paper breakdown → | 2014 | 362 |
| 16 | Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study Hit paper breakdown → | 2016 | 306 |
| 17 | 2004 | 305 | |
| 18 | 2011 | 290 | |
| 19 | 2010 | 288 | |
| 20 | 2011 | 270 |
About Daniel Weintraub
Daniel Weintraub is a scholar working on Neurology, Psychiatry and Mental health, Clinical Psychology, Physiology and Cognitive Neuroscience, having authored 369 papers that have together received 28.5k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (226 papers), Neurological disorders and treatments (69 papers), Dementia and Cognitive Impairment Research (58 papers), Alzheimer's disease research and treatments (21 papers), Obsessive-Compulsive Spectrum Disorders (17 papers), Autism Spectrum Disorder Research (16 papers), Restless Legs Syndrome Research (14 papers) and Attention Deficit Hyperactivity Disorder (11 papers). The work is most often cited by research in Neurology (17.7k citations), Psychiatry and Mental health (4.5k citations), Neurology (1.6k citations), Cognitive Neuroscience (3.7k citations) and Cellular and Molecular Neuroscience (3.4k citations). Daniel Weintraub has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Andrew Siderowf, Dag Aarsland, John E. Duda, Matthew B. Stern, К. Ray Chaudhuri, Sharon X. Xie, David J. Burn, Marc N. Potenza, Paul J. Moberg and Clive Ballard. Their work appears in journals such as Movement Disorders, Parkinsonism & Related Disorders, American Journal of Geriatric Psychiatry, Neurology and Journal of Parkinson s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.